The Omega-3 Index (EPA+DHA) quantifies the combined percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell membranes, a marker of long-term omega-3 status.
Omega-3-Index (EPA+DHA) is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Omega-3-Index (EPA+DHA) is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
Omega-3-Index (EPA+DHA) does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
The Omega-3 Index (EPA+DHA) specifically reports the sum of EPA and DHA as a proportion of all fatty acids in the membranes of red blood cells. Because these two omega-3 fatty acids are primarily obtained from marine foods, the index serves as a reliable indicator of dietary intake over several months.
In the body, EPA and DHA contribute to cell membrane fluidity, resolve inflammation, and support cardiovascular and cognitive functions. Routine measurement is used to evaluate whether a person meets the suggested target of 8% or greater (lab-dependent range: 8–12%), which population data link to better heart health outcomes.
A value below the typical reference interval (commonly under 8%) may point to a diet low in EPA and DHA. Low EPA+DHA levels have been associated with a higher risk of cardiovascular disease in epidemiological studies and may warrant dietary adjustments or supplementation after consulting a healthcare provider.
A result exceeding the usual upper bound (around 12%) is typically seen only with high-dose omega-3 supplementation. Although no firm toxicity level exists, very high EPA+DHA can potentially influence bleeding time; therefore, it is prudent to seek medical advice regarding supplement dosage.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Omega-3-Index (EPA+DHA) is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Omega-3 Index (EPA+DHA) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
It measures the combined percentage of EPA and DHA in the membranes of red blood cells. This value reflects long-term dietary intake of these important omega-3 fatty acids.
A healthy target is 8% or more, with a typical reference range of 8–12% (lab-dependent). Achieving this level is linked to a lower risk of heart disease in observational research.
Low EPA+DHA (often below 8%) suggests insufficient omega-3 intake. This pattern has been associated with increased cardiovascular risk and may indicate a need for more fatty fish or omega-3 supplements in the diet.
While moderately high EPA+DHA levels (above 12%) are generally safe and primarily seen with supplementation, extremely high intakes may have mild effects on blood clotting. It is best to discuss high-dose omega-3 use with a healthcare professional.
Omega-3-Index (EPA+DHA) does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://biogena.com/en/knowledge/guide/omega-3-deficiency_bba_4287742
biogena.com
https://www.healthline.com/health/nutrition/omega-3-insufficiency-in-the-u-s
healthline.com
https://purazell.de/blog/omega-3-mangel/
purazell.de
https://pubmed.ncbi.nlm.nih.gov/15208005/
pubmed.ncbi.nlm.nih.gov
https://www.burgerstein-foundation.ch/de-DE/fachbereich/aktuelles-aus-wissenschaft-praxis/der-omega-3-index-ein-laborparameter-mit-hoher-praventiver-bedeutung
burgerstein-foundation.ch
https://www.imd-berlin.de/fachinformationen/diagnostikinformationen/fettsaeurestatus-der-erythrozytenmembran
imd-berlin.de
https://www.ugb.de/exklusiv/fragen-service/was-ist-wozu-dient-omega-3-index/?omega-3-index-omega-3-fettsaeuren
ugb.de
https://labor-augsburg-mvz.de/aktuelles/update-omega-3-index-omega-6-3-quotient-sowie-arachidonsaeureeicosapentaensaeure-quotient
labor-augsburg-mvz.de
https://www.ndr.de/ratgeber/gesundheit/Lebenswichtige-Omega-3-Fettsaeuren-Richtige-Dosierung-entscheidend,fettsaeuren100.html
ndr.de
https://www.laborteam.ch/de/profile/8749
laborteam.ch
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
